Clinical Trial: Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian Cancer

U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07764133) titled 'Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian Cancer' on Aug. 05.

Brief Summary: The primary objectives of the study are:

1. To delineate commonly utilized tumor metabolic alterations in ovarian cancer. These metabolic alterations will be explored for potentially targetable pathways to restore chemotherapy responsiveness.

2. To define the relationship between whole-body metabolic activity as measured via indirect calorimetry with ex vivo measure of tumor metabolic activity.

The secondary objectives of the study are:

3. To evaluate longitudinal chan...